We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

16 hedge funds and large institutions have $257K invested in Catheter Precision in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

20% less funds holding

Funds holding: 20 → 16 (-4)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

39% less capital invested

Capital invested by funds: $420K → $257K (-$163K)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APP
Avantax Planning Partners
Iowa
+$18.5K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$12.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$6.18K
4
SG
StoneX Group
New York
+$3.09K
5
WAP
Wealthcare Advisory Partners
Pennsylvania
+$3.09K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$40.2K
2
Citigroup
Citigroup
New York
-$15.5K
3
Two Sigma Investments
Two Sigma Investments
New York
-$15.5K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$11K
5
UBS Group
UBS Group
Switzerland
-$9.27K

VTAK Hedge Fund Activity: Q2 2022 in Review

16 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2022, worth a combined $257K — down 39% from $420K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VTAK and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Avantax Planning Partners, adding an estimated $18.5K. The largest seller was Virtu Financial, cutting an estimated $40.2K.

  • 16 institutional investors held Catheter Precision (VTAK) as of Q2 2022, down from 20 in Q1 2022.
  • Funds reported $257K of Catheter Precision stock for Q2 2022, down 39% quarter-over-quarter.
  • 3 funds opened new Catheter Precision positions in Q2 2022 and 6 closed out, a net change of -3 holders.
  • The largest Catheter Precision buyer in Q2 2022 was Avantax Planning Partners, an estimated $18.5K added.
  • The largest Catheter Precision seller in Q2 2022 was Virtu Financial, an estimated $40.2K sold.

Based on aggregated 13F filings for Q2 2022.